Chemokine receptors on human regulatory T cells during cutaneous leishmaniasis

The aim of this work was to define the population of regulatory T cells (Tregs) which are circulating in the blood of Leishmania infected individuals clinically displaying a lesion (active disease–AD) and sub‐clinical (SC) ones. We have individually collected blood samples, processed the PBMC and stained with fluorochrome‐conjugated antibodies against CD3, CD4, Foxp3, CD25, CTLA‐4, Ki‐67, CCR4, CCR5, and CCR7. Cells were analyzed by flow cytometry. Our results suggest that CD25 and CTLA‐4 are upregulated in Tregs of AD patients when compared to SC and uninfected (UN) controls. Moreover, Tregs proliferate upon infection based on Ki‐67 nuclear antigen staining. Finally, we have observed that these Tregs of SC and AD patients upregulate CCR4, but not CCR5 and CCR7. There is an increase in the number of circulating Tregs in the blood of Leishmania infected individuals. These cells are potentially more suppressive based on the increased upregulation of CD25 and CTLA‐4 during clinical infection (AD) when compared to SC infection. Tregs of both SC and AD cohorts are proliferating and express CCR4, which potentially guide them to the skin, but do not upregulate CCR5 and CCR7.

[1]  M. Brito,et al.  Leishmania V. braziliensis infection in asymptomatic domestic animals within an endemic region in the Northeast of Brazil , 2022, Revista da Sociedade Brasileira de Medicina Tropical.

[2]  C. Bogdan,et al.  Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of Leishmania major Infection , 2022, Pathogens.

[3]  Amrita Saha,et al.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis , 2022, Infection and immunity.

[4]  C. Freire-de-Lima,et al.  Immune Responses in Leishmaniasis: An Overview , 2022, Tropical medicine and infectious disease.

[5]  O. Boyman,et al.  CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection , 2022, Science Immunology.

[6]  D. Shen,et al.  CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma , 2021, Annals of translational medicine.

[7]  E. von Stebut,et al.  Unraveling the Role of Immune Checkpoints in Leishmaniasis , 2021, Frontiers in Immunology.

[8]  Sunil Martin,et al.  Cytokines in the generation and function of regulatory T cell subsets in Leishmaniasis. , 2020, Cytokine.

[9]  D. Shevyrev,et al.  Treg Heterogeneity, Function, and Homeostasis , 2020, Frontiers in Immunology.

[10]  A. White,et al.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis. , 2018, The American journal of tropical medicine and hygiene.

[11]  G. Garlet,et al.  CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development , 2017, Molecular Cancer Therapeutics.

[12]  E. von Stebut,et al.  In cutaneous leishmaniasis, induction of retinoic acid in skin-derived Langerhans cells is not sufficient for induction of parasite persistence-mediating regulatory T cells. , 2017, Journal of dermatological science.

[13]  Philippe Jay,et al.  The cell proliferation antigen Ki-67 organises heterochromatin , 2016, eLife.

[14]  F. Riazi-rad,et al.  FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases. , 2014, Human immunology.

[15]  Rainer Sauerborn,et al.  Human health: impacts, adaptation, and co-benefits , 2014 .

[16]  Adriano Queiroz,et al.  Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis. , 2013, Human immunology.

[17]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[18]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[19]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[20]  C. Mendes-Aguiar,et al.  The skin homing receptor cutaneous leucocyte‐associated antigen (CLA) is up‐regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis , 2009, Clinical and experimental immunology.

[21]  J. Blay,et al.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.

[22]  F. Tacchini-Cottier,et al.  Intralesional Regulatory T-Cell Suppressive Function during Human Acute and Chronic Cutaneous Leishmaniasis Due to Leishmania guyanensis , 2009, Infection and Immunity.

[23]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[24]  Y. Belkaid.  Regulatory T cells and infection: a dangerous necessity , 2007, Nature Reviews Immunology.

[25]  T. Yoshimoto,et al.  Dendritic Cell-Derived IL-12p40 Homodimer Contributes to Susceptibility in Cutaneous Leishmaniasis in BALB/c Mice1 , 2007, The Journal of Immunology.

[26]  J. Mora,et al.  T-cell homing specificity and plasticity: new concepts and future challenges. , 2006, Trends in immunology.

[27]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[28]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[29]  Yasmine Belkaid,et al.  Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity , 1998, The Journal of experimental medicine.